Speaker

Donna R. Rivera, PharmD., MSc., is the Associate Director for Pharmacoepidemiology in the Oncology Center of Excellence at the U.S. Food and Drug Administration. She leads the Oncology Real World Evidence (RWE) Program, focused on the use of Real World Data (RWD) and RWE for regulatory purposes, as well as management of the RWD research portfolio strategy and development of regulatory policy to support the OCE mission. As a pharmacist and pharmacoepidemiologist, Dr. Rivera has interests in the use of RWD to advance health equity, observational study designs and methodological approaches, and appropriate uses of RWD for drug development to increase access of effective therapies to patients.